Wednesday, May 29, 2024
More
    HomeNewsEU visit to vaccine plant under scrutiny over AstraZeneca delays

    EU visit to vaccine plant under scrutiny over AstraZeneca delays

    The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca’s COVID-19 vaccine.
    [penci_ads id=”penci_ads_1″]

    euronews (in English)

    #visit #vaccine #plant #scrutiny #AstraZeneca #delays

    - Advertisement -
    RELATED ARTICLES
    - Advertisment -

    Most Popular